NOV-DEC 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 62 of 68

NEWS & EVENTS 60 NOVEMBER/DECEMBER 2018 | MedEsthetics "Candela is committed to developing and enhancing innovative technological solutions that change lives. Our partnership with the Vascular Birthmarks Foundation and Dr. Roy Geronemus refl ects this commitment," said Geoffrey Crouse, CEO of Candela. "We are honored to offer these pro-bono treatments with the gold standard Vbeam pulsed dye laser to continue our mission to improve patients' quality of life." For more information about the Vascular Birthmarks Foundation, visit AIVITA APPOINTS NEW SENIOR LEADERS Scott Burell is now chief fi nancial offi cer of AIVITA Biomedical and Kevin Green is the company's new vice president of business de- velopment. AIVITA Biomedical is a biotech company specializing in stem cell applications, including ovarian cancer and glioblastoma. The company also manufactures two skincare lines, ROOT OF SKIN and ROOT OF SKIN MD, which include a proprietary actives complex containing the natural ingredients of skin stem cells. Burell brings more than 25 years of corporate fi nance experience ranging from M&A to strategic management, operational manage- ment, fi nancial reporting and compliance to the position. Prior to joining AIVITA, he served as CFO of CombiMatrix Corporation. Green previously served as senior director of business development at Allergan for 10 years. "Mr. Burell and Mr. Green bring decades of B2B, corporate fi nance and capital raising experience to AIVITA," said Dr. Hans S. Keirstead, AIVITA's chairman and CEO. "These appointments refl ect our plans for further capitalization via investment and partnership." The company recently announced that the University of Califor- nia, Irvine's Comprehensive Brain Tumor Program and the UCLA- UCI Alpha Stem Cell Clinic have received IRB approval to begin re- cruiting patients with newly diagnosed glioblastoma for a phase 2 trial of AIVITA's platform ROOT OF CANCER treatment. The technolo- gy is also currently the subject of a Phase 2 clinical trial in ovarian can- cer in the U.S. and a commercialization effort in melanoma in Japan. SYNERON CANDELA ACQUIRES ELLIPSE Syneron Candela, a global aesthetic device company, has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic skin treatments. Ellipse's key products include Nordlys, a multi-application, multi- technology IPL and Nd:YAG platform for vascular and pigmented lesions as well as hair removal. The Nordlys also offers a fractionated PUBLICATION TITLE PUBLICATION NO. FILING DATE MedEsthetics 1937-2140 10-02-2018 ISSUE FREQUENCY NO. OF ISSUES PUBLISHED ANNUALLY ANNUAL SUBSCRIPTION PRICE Monthly, except in February, 8 $48.00 June, August and December OWNER MAILING ADDRESS Creative Age Communications, Inc. 7628 Densmore Ave., Van Nuys, CA 91406-2042 Deborah Carver 7628 Densmore Ave., Van Nuys, CA 91406-2042 KNOWN BONDHOLDERS, MORTGAGEES & OTHER SECURITY HOLDERS OWNING OR HOLDING 1 PERCENT OR MORE OF TOTAL AMOUNT OF BONDS, MORTGAGES OR OTHER SECURITIES. NONE. COMPLETE MAILING ADDRESS OF KNOWN OFFICE OF PUBLICATION 7628 Densmore Ave., Van Nuys, Los Angeles Cty., CA 91406-2042 COMPLETE MAILING ADDRESS OF PUBLISHER'S HEADQUARTERS 7628 Densmore Ave., Van Nuys, CA 91406-2042 FULL NAMES AND COMPLETE MAILING ADDRESSES OF PUBLISHER, EDITOR & MANAGING EDITOR PUBLISHER: Deborah Carver, Creative Age Communications, Inc., 7628 Densmore Ave., Van Nuys, CA 91406-2042 EDITOR: Inga Hansen, Creative Age Communications, Inc., 7628 Densmore Ave., Van Nuys, CA 91406-2042 MANAGING EDITOR: NONE. Statement of Ownership, Management, and Circulation (Required by 39 U.S.C. 3685) I CERTIFY THAT ALL INFORMATION FURNISHED ON THIS FORM IS TRUE AND COMPLETE. I UNDERSTAND THAT ANYONE WHO FURNISHES FALSE OR MISLEADING INFORMATION ON THIS FORM OR WHO OMITS MATERIAL OR INFORMATION REQUESTED ON THE FORM MAY BE SUBJECT TO CRIMINAL SANCTIONS (INCLUDING FINES AND IMPRISONMENT) AND/OR CIVIL SANCTIONS (INCLUDING MULTIPLE DAMAGES AND CIVIL PENALTIES). Deborah Carver, Publisher/CEO Filed on 10-02-2018 TOTAL NO. COPIES (NET PRESS RUN) 21,092 20,096 PAID/REQUESTED CIRCULATION 1. SALES THROUGH DEALERS & CARRIERS 0 0 2. PAID/REQUESTED SUBSCRIPTIONS 13,416 13,112 **TOTAL PAID/REQUESTED CIRCULATION 13,416 13,112 FREE DISTRIBUTION BY MAIL 7,039 6,653 FREE DISTRIBUTION OUTSIDE MAIL 422 115 **TOTAL FREE DISTRIBUTION 7,461 6,768 TOTAL DISTRIBUTION 20,877 19,880 COPIES NOT DISTRIBUTED 1. OFFICE USE 215 216 2. RETURN FROM NEWS AGENTS 0 0 **TOTAL COPIES NOT DISTRIBUTED 215 216 TOTAL COPIES PRINTED 21,092 20,096 REQUESTED & PAID ELECTRONIC COPIES 666 739 TOTAL REQUESTED/PAID PRINT & ELECTRONIC CIRCULATION: 14,082 13,851 TOTAL DISTRIBUTION 21,541 20,619 EXTENT & NATURE AVG. NO. COPIES EACH ISSUE ACTUAL NO. COPIES OF CIRCULATION DURING LAST 12 MONTHS CURRENT SINGLE ISSUE Subscribe by calling 800.624.4196 Or visit › Review new content before the print edition arrives › Share relevant articles with colleagues and staff › Search content by keyword for topics of interest › View and search past issues of MedEsthetics View MedEsthetics on your tablet. Subscribe to the MedEsthetics Digital Edition to:

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - NOV-DEC 2018